Company profile
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NRX Pharmaceuticals, Inc.
24 Aug 23
4
NRX Pharmaceuticals, Inc.
23 Aug 23
5
NRX Pharmaceuticals, Inc.
14 Feb 23
4
NRX Pharmaceuticals, Inc.
9 Dec 22
SC 13D/A
NRX Pharmaceuticals, Inc.
17 Jun 22
SC 13D
NRX Pharmaceuticals, Inc.
3 Jun 22
4/A
NRX Pharmaceuticals, Inc.
2 Jun 22
4
NRX Pharmaceuticals, Inc.
2 Jun 22
SC 13D/A
NRX Pharmaceuticals, Inc.
2 Nov 21
4
NRX Pharmaceuticals, Inc.
10 Jun 21
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Aug 23 | Javitt Jonathan C | Common Stock | Buy | Acquire P | No | No | 0.33 | 100,000 | 33.00 k | 446,332 |
22 Aug 23 | Javitt Jonathan C | Common Stock | Buy | Acquire P | No | No | 0.322 | 200,000 | 64.40 k | 346,332 |
14 Dec 22 | Javitt Jonathan C | Common Stock, par value $0.001 per share | Gift | Dispose G | Yes | No | 0 | 300,000 | 0.00 | 14,468,329 |
7 Dec 22 | Javitt Jonathan C | Common Stock, par value $0.001 per share | Sell | Dispose S | Yes | No | 1 | 400,000 | 400.00 k | 12,899,997 |